Management of BCG "Failures".
作者信息
Palou Redorta Juan
出版信息
Eur Urol. 2006 May;49(5):779-80. doi: 10.1016/j.eururo.2006.03.006. Epub 2006 Mar 20.
PMID:16616207
Abstract
摘要
相似文献
1
Management of BCG "Failures".卡介苗“接种失败”的管理
Eur Urol. 2006 May;49(5):779-80. doi: 10.1016/j.eururo.2006.03.006. Epub 2006 Mar 20.
2
Management of BCG failures in superficial bladder cancer: a review.浅表性膀胱癌中卡介苗治疗失败的管理：综述
Eur Urol. 2006 May;49(5):790-7. doi: 10.1016/j.eururo.2006.01.017. Epub 2006 Jan 24.
3
Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.高危Ta、T1期膀胱癌诱导使用卡介苗后的复发模式及预后
J Urol. 2007 May;177(5):1727-31. doi: 10.1016/j.juro.2007.01.031.
4
[International Consensus Panel--treatment strategies for superficial bladder cancer].[国际共识小组——浅表性膀胱癌的治疗策略]
Aktuelle Urol. 2006 Sep;37(5):320-3; discussion 322-3. doi: 10.1055/s-2006-951427.
5
[ BCG-immunotherapy and bladder cancer].[卡介苗免疫疗法与膀胱癌]
Prog Urol. 2008 May;18 Suppl 5:S93. doi: 10.1016/S1166-7087(08)72483-7.
6
What is the optimal BCG dose in non-muscle-invasive bladder cancer?非肌层浸润性膀胱癌的最佳卡介苗剂量是多少？
Eur Urol. 2007 Nov;52(5):1300-2. doi: 10.1016/j.eururo.2007.05.010. Epub 2007 May 22.
7
8
[BCG therapy. Its role in the treatment of tumors of the bladder].[卡介苗疗法。其在膀胱肿瘤治疗中的作用]
Ann Urol (Paris). 1995;29(5):292-3.
9
[Intravesical instillation for bladder tumors].[膀胱肿瘤的膀胱内灌注]
Rev Prat. 2014 Dec;64(10):1388-9.
10
Treatment of BCG failures with intravesical BCG/Interferon: the University of Montreal experience.膀胱内卡介苗/干扰素治疗卡介苗治疗失败的病例：蒙特利尔大学的经验
Can J Urol. 2006 Aug;13(4):3189-94.
引用本文的文献
1
Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy.高复发/进展风险的表达唾液酸化-Tn 和唾液酸化-6-T 的膀胱肿瘤对卡介苗免疫治疗的反应。
Br J Cancer. 2013 Oct 15;109(8):2106-14. doi: 10.1038/bjc.2013.571. Epub 2013 Sep 24.
Zotero 插件